900120 — CXI Healthcare Technology Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩37bn
- -KR₩16bn
- CNY238.58m
Annual cashflow statement for CXI Healthcare Technology, fiscal year end - June 30th, CNY millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 32.2 | 39.6 | 159 | 70.9 | 38.9 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 9.43 | 1.63 | -54 | -20.1 | -19.5 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 15.6 | 4.68 | -2.52 | 37.9 | 17.3 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 187 | 175 | 229 | 213 | 171 |
| Capital Expenditures | -0.03 | — | — | -0.296 | -1,021 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.759 | -0.14 | 86.7 | 0.976 | 0.403 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0.729 | -0.14 | 86.7 | 0.68 | -1,021 |
| Financing Cash Flow Items | -0.025 | -0.015 | 5.57 | -0.021 | -0.057 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 6 | 8.04 | 1.33 | 6.94 | 59.4 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 193 | 182 | 317 | 220 | -792 |